Marjorie Eiref, Head of Operations for Neuroscience Research at Novartis, describes how her family medical history has impacted her career.

The best treatment for multifaceted diseases like NASH may be combinations of drugs.

Read how two sites within the Novartis Technical Operations (NTO) network ensured business continuity at scale and speed in the midst of the COVID-19 pandemic.

Melanoma survivor T.J. Sharpe shares why patients should know their treatment options.

Novartis CEO Vas Narasimhan answers questions about COVID-19.